Search

Byline: By, Tom Harle Kadeena Cox was inconsolable Kadeena Cox left distraught as Paralympic gold medal hopes end in concerning fashion The reigning time trial champion and world record holder [...]

Byline: By, Sam Volpe A Newcastle man has lost around two stone in under a year after being inspired to lose weight to support his wife who has Multiple Sclerosis. [...]

Byline: By, Steven Smith A said she was left to go to the toilet in a bucket and clean herself with 'wet wipes' after 'cowboy builders' ran off without notice [...]

Byline: By, Steven Smith A disabled woman was forced to clean herself with 'wet wipes' and urinate in a bucket after 'cowboy builders' whom she paid £22,000 to 'smashed' her [...]

MINISTRY OF PUBLIC HEALTH AND SOCIAL WELFARE (MSPBS), Paraguay has invited tenders for Lpn N 102/24 Acquisition of Medicines for the Multiple Sclerosis Program. Tender Notice No: 445967 Deadline: August [...]

Byline: Trisha Pasricha; MD It seems like everyone I talk to has a diagnosis of some new autoimmune condition. What is going on? Your observation is accurate. Autoimmune diseases are [...]

Byline: Trisha Pasricha, MD It seems like everyone I talk to has a diagnosis of some new autoimmune condition. What is going on? - - - Your observation is accurate. [...]

Audrey Mae Piansky, 82, of Atlanta, formerly of New York, passed away on July 29, 2024. Born in Brooklyn, NY, Audrey attended Lafayette High School before earning her Bachelors degree [...]

Byline: Sally Weale Education correspondent A primary school headteacher with multiple sclerosis (MS) has been paid damages in a landmark disability discrimination case against Ofsted, after her request to postpone [...]

Byline: By, Samantha Leathers Sara Morris has been found guilty of fraudulently claiming Personal Independence Payments, or PIP, since 2020. She was diagnosed with Multiple Sclerosis in 2005 but was [...]

Byline: Michael Searles HEALTH CORRESPONDENT A MULTIPLE sclerosis jab that cuts treatment time by 90 per cent is set to be rolled out on the NHS. About 9,000 patients with [...]

Byline: Andrew Gregory Health editor Thousands of people with multiple sclerosis in England are to benefit from a 10-minute injection that cuts the time they need to spend in hospital [...]

Byline: By, Samantha Leathers Sara Morris has been found guilty of fraudulently claiming Personal Independence Payments, or PIP, since 2020. She was diagnosed with Multiple Sclerosis in 2005 but was [...]

Byline: By, Samantha Leathers Sara Morris has been found guilty of fraudulently claiming Personal Independence Payments, or PIP, since 2020. She was diagnosed with Multiple Sclerosis in 2005 but was [...]

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Diroximel Fumarate Delayed-Release Capsules, 231 mg (USRLD: Vumerity? Delayed-Release Capsulestablets).Diroximel Fumarate Delayed-Release Capsules [...]

AUSTIN, Texas: NeuFit has issued the following news release: Hundreds of individuals living with Multiple Sclerosis (MS) have seen vast improvements in their symptoms by incorporating the NeuFit Method into [...]

AUSTIN, Texas, Sept. 9, 2024 /PRNewswire/ -- Hundreds of individuals living with Multiple Sclerosis (MS) have seen vast improvements in their symptoms by incorporating the NeuFit Method into their daily [...]

-- Investigator Study Sponsored by Goethe University Frankfurt (Germany), Funded via a German Government Grant; Study Drug Vidofludimus Calcium Provided by Immunic -- -- In Addition to Post COVID Readouts, [...]

SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, 'Clene') and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]

Overview Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In (myelin oligodendrocyte glycoprotein antibody-associated disease) MOGAD, the immune [...]

(GLOBE NEWSWIRE via COMTEX) -- Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis [...]

Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis In the HERCULES study, tolebrutinib [...]

LOS ANGELES: Quantum BioPharma Ltd. (QNTM) marks a significant milestone with the successful launch of unbuzzdtm on Amazon. This development coincides with the Company's rebranding and ticker change to QNTM. [...]

NEW YORK: Immunic, Inc has issued the following press release: Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory [...]

NEW YORK, Aug. 28, 2024 /PRNewswire/ --https://c212.net/c/link/?t=0&l=en&o=4241156-1&h=202615933&u=https%3A%2F%2Fimux.com%2F&a=Immunic%2C+Inc.(Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that [...]

Ottawa, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The global https://www.globenewswire.com/Tracker?data=bIp7txxpZUJiX0zowb0rIytr5sZYisJUQvJCfPz3EiZ1Km4QA3oU2pM6r7X0UZhWgYU1VqZv1f3mzs2Wqxa5hQTGVp_upfEsSLa9gAl6zh-y_NyO8RO2BFLscyVJ9tdT7TkFWMBFql3_hMBghqrdpMZ9iuqaqElWITcbEfougAYfMA4vk5Xn6yfxyF_un4VD_I3-ahSQiMBZX_s1uFxFMV8PMjCxxaYfR887frh21Dyr05fn8OjTE9EEiWm9iUra size was valued at USD 22.14 billion in 2023 and is predicted to hit around USD 28.48 billion by 2031, [...]

In this free webinar, our featured experts will explore recent studies demonstrating the practical applications and benefits of applying AI-based technologies to multiple sclerosis (MS) clinical trials. Topics of the [...]

Mont-Saint-Guibert: BioSenic, the clinical-stage company specializing in serious autoimmune and inflammatory diseases, announced that the European Patent Office (EPO) has granted an important new EU patent to its subsidiary Medsenic [...]

LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via https://www.globenewswire.com/Tracker?data=yk5yuuEBSi0Kg2RajGYLSgb7pXIJYZnNVwUY9MeRWT4g1lOHK2d6E2SZCzp34pw4wQrTPLMtratD--1VG7bUAA== - https://www.globenewswire.com/Tracker?data=uC1MZvfA11rWYWtfm4VQLaEJkh7-mywt4eSQm4cIL5gm2UfBsCpKrRqMseX-9gWZycie4zvqkh4IiJ65ps-6tQ==, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the [...]

MENLO PARK, Calif. -- Octave([R]) Bioscience, a leading precision care company transforming the management of multiple sclerosis (MS) and other neurodegenerative diseases, today announced the appointment of Marcel Konrad as [...]

STORRS, Conn. -- The following information was released by the University of Connecticut: Kim Krieger - UConn Communications Multiple sclerosis affects about a million people in the US, and millions [...]

STAMFORD, Conn. -- HealthCare Royalty ('HCRx'), in conjunction with funds managed by Blue Owl Capital ('Blue Owl'), has entered into a $250 million term loan facility (the 'Initial Term Loan') [...]

SALT LAKE CITY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, 'Clene') and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]

CLINTON, Md. -- The following information was released by MedStar Health: MedStar Southern Maryland Hospital Center has been designated as a Comprehensive Multiple Sclerosis (MS) Care Center through the National […]

Stephanie Buxhoeveden Will Lead iConquerMS(TM) People-Powered Research Network and Other Research WALTHAM, Mass., July 31, 2024 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) announced today that it [...]

Winter Park: ADIA Nutrition Inc. announces a significant development in the company's strategic growth plan. CEO Larry Powalisz has committed to providing ADIA Nutrition with an up to $500,000 line [...]

-- Senior Executive and Thought Leader in Brain Health with Nearly Three Decades of Global Pharmaceutical Experience -- -- Served as Neuroimmunology Franchise Head Responsible for Roche's Blockbuster Launch of [...]

Description A disease in which the immune system breaks down the protective coating of nerve fibers in the brain and spinal cord, called the myelin sheath. Overview Genetics and environmental [...]

Winter Park: ADIA Nutrition Inc., announces a strategic restructuring initiative aimed at enhancing its offerings and expanding its market reach. With a clear vision for growth and innovation, ADIA Nutrition [...]

Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=TrFJNIEFECGVO72oT6QkqVYoYy78tdTFQ9UE_Dt1fVOYZ5O1nAsUePquTZNPRnjJMVSp6Ogw1xpI9nxIrIcBxw== (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a clinical-stage [...]

GENEVA: GENEURO has issued the following news release: GeNeuro (Euronext Paris : CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis [...]